Relief Therapeutics Holding SA (RLFTF)
OTCMKTS · Delayed Price · Currency is USD
4.060
-0.240 (-5.58%)
Oct 2, 2025, 2:18 PM EDT

RLFTF Statistics

Total Valuation

RLFTF has a market cap or net worth of 51.46 million. The enterprise value is 38.19 million.

Market Cap51.46M
Enterprise Value 38.19M

Important Dates

The next estimated earnings date is Thursday, April 2, 2026.

Earnings Date Apr 2, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 12.58M
Shares Outstanding n/a
Shares Change (YoY) +0.52%
Shares Change (QoQ) +0.10%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 10.10
PB Ratio 1.25
P/TBV Ratio 19.89
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.78
EV / Sales 7.52
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -8.59

Financial Position

The company has a current ratio of 4.05, with a Debt / Equity ratio of 0.06.

Current Ratio 4.05
Quick Ratio 3.72
Debt / Equity 0.06
Debt / EBITDA n/a
Debt / FCF -0.54
Interest Coverage -226.67

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -18.45%
Revenue Per Employee 182,056
Profits Per Employee -765,229
Employee Count31
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -3.55M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +38.49% in the last 52 weeks. The beta is -0.39, so RLFTF's price volatility has been lower than the market average.

Beta (5Y) -0.39
52-Week Price Change +38.49%
50-Day Moving Average 3.39
200-Day Moving Average 3.32
Relative Strength Index (RSI) 69.25
Average Volume (20 Days) 3,123

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, RLFTF had revenue of 5.10 million and -21.43 million in losses. Loss per share was -1.71.

Revenue5.10M
Gross Profit 3.07M
Operating Income -10.26M
Pretax Income -24.98M
Net Income -21.43M
EBITDA -8.53M
EBIT -10.26M
Loss Per Share -1.71
Full Income Statement

Balance Sheet

The company has 15.72 million in cash and 2.39 million in debt, giving a net cash position of 13.33 million.

Cash & Cash Equivalents 15.72M
Total Debt 2.39M
Net Cash 13.33M
Net Cash Per Share n/a
Equity (Book Value) 41.03M
Book Value Per Share 3.26
Working Capital 14.38M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.41 million and capital expenditures -32,693, giving a free cash flow of -4.45 million.

Operating Cash Flow -4.41M
Capital Expenditures -32,693
Free Cash Flow -4.45M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 60.24%
Operating Margin -201.28%
Pretax Margin -489.96%
Profit Margin n/a
EBITDA Margin -167.24%
EBIT Margin -201.28%
FCF Margin n/a

Dividends & Yields

RLFTF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.52%
Shareholder Yield n/a
Earnings Yield -41.63%
FCF Yield -8.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on May 5, 2023. It was a reverse split with a ratio of 0.0025.

Last Split Date May 5, 2023
Split Type Reverse
Split Ratio 0.0025

Scores

RLFTF has an Altman Z-Score of -5.74 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.74
Piotroski F-Score 1